Fusion Pharmaceuticals Inc (FUSN)
21.45
-0.04
(-0.19%)
USD |
NASDAQ |
May 03, 16:00
21.44
-0.02
(-0.07%)
After-Hours: 20:00
Fusion Pharmaceuticals Price to Book Value: 8.166 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 8.166 |
| May 02, 2024 | 8.181 |
| May 01, 2024 | 8.154 |
| April 30, 2024 | 8.158 |
| April 29, 2024 | 8.146 |
| April 26, 2024 | 8.154 |
| April 25, 2024 | 8.146 |
| April 24, 2024 | 8.146 |
| April 23, 2024 | 8.154 |
| April 22, 2024 | 8.116 |
| April 19, 2024 | 8.093 |
| April 18, 2024 | 8.089 |
| April 17, 2024 | 8.086 |
| April 16, 2024 | 8.093 |
| April 15, 2024 | 8.101 |
| April 12, 2024 | 8.112 |
| April 11, 2024 | 8.131 |
| April 10, 2024 | 8.131 |
| April 09, 2024 | 8.139 |
| April 08, 2024 | 8.146 |
| April 05, 2024 | 8.116 |
| April 04, 2024 | 8.158 |
| April 03, 2024 | 8.124 |
| April 02, 2024 | 8.105 |
| April 01, 2024 | 8.089 |
| Date | Value |
|---|---|
| March 28, 2024 | 8.116 |
| March 27, 2024 | 8.108 |
| March 26, 2024 | 8.108 |
| March 25, 2024 | 8.063 |
| March 22, 2024 | 8.086 |
| March 21, 2024 | 8.070 |
| March 20, 2024 | 8.028 |
| March 19, 2024 | 8.063 |
| March 18, 2024 | 4.050 |
| March 15, 2024 | 3.803 |
| March 14, 2024 | 3.556 |
| March 13, 2024 | 3.616 |
| March 12, 2024 | 3.609 |
| March 11, 2024 | 3.586 |
| March 08, 2024 | 3.597 |
| March 07, 2024 | 3.593 |
| March 06, 2024 | 3.546 |
| March 05, 2024 | 3.762 |
| March 04, 2024 | 3.865 |
| March 01, 2024 | 4.295 |
| February 29, 2024 | 4.284 |
| February 28, 2024 | 4.370 |
| February 27, 2024 | 4.478 |
| February 26, 2024 | 4.532 |
| February 23, 2024 | 4.349 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4363
Minimum
Aug 11 2022
12.70
Maximum
Jun 29 2020
1.684
Average
1.387
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 6.322 |
| Landos Biopharma Inc | 2.180 |
| Perspective Therapeutics Inc | 14.13 |
| Acasti Pharma Inc | 0.4302 |
| Aurinia Pharmaceuticals Inc | 1.930 |
Price to Book Value Related Metrics
| PS Ratio | 636.99 |
| Price | 21.45 |
| Earnings Yield | -6.85% |
| Market Cap | 1.817B |